Obesity and other cancers

Journal of Clinical Oncology

Volumn 34, Issue 35, 2016, Pages 4231-4237

  Yang, Lin ^a   Drake, Bettina F ^a   Colditz, Graham A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; DIFFUSE LARGE B CELL LYMPHOMA; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; MALE; MULTIPLE MYELOMA; NON PROFIT ORGANIZATION; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; COMPLICATION; FEMALE; HEMATOLOGIC DISEASE; KIDNEY TUMOR; MORTALITY; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR;

FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; MALE; OBESITY; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 85002520951     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.68.4837     Document Type: Review

References (79)

1. International Agency for Research on Cancer: Weight Control and Physical Activity. Lyon, France, International Agency for Research on Cancer, 2002
2. Lauby-Secretan B, Scoccianti C, Loomis D, et al: Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med 375:794-798, 2016
3. Calle EE, Rodriguez C, Walker-Thurmond K, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 348:1625-1638, 2003
4. Cao Y, Ma J: Bodymass index, prostatecancerspecific mortality, and biochemical recurrence: A systematic reviewandmeta-analysis. Cancer Prev Res (Phila) 4:486-501, 2011
5. Larsson SC, Wolk A: Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: A metaanalysis of prospective studies. Eur J Cancer 47:2422-2430, 2011
6. Castillo JJ, Reagan JL, Ingham RR, et al: Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies. Leuk Res 36:868-875, 2012
7. Castillo JJ, Mulkey F, Geyer S, et al: Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. Am J Hematol 91:199-204, 2016
8. Breccia M, Mazzarella L, Bagnardi V, et al: Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols. Blood 119:49-54, 2012
9. Amankwah EK, Saenz AM, Hale GA, et al: Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: A systematic review and meta-analysis. Leuk Lymphoma 57:1140-1148, 2016
10. Wallin A, Larsson SC: Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies. Eur J Cancer 47:1606-1615, 2011
11. Teras LR, Kitahara CM, Birmann BM, et al: Body size and multiple myeloma mortality: A pooled analysis of 20 prospective studies. Br J Haematol 166:667-676, 2014
12. Donin NM, Pantuck A, Klöpfer P, et al: Body mass index and survival in a prospective randomized trial of localized high-risk renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 25:1326-1332, 2016
13. Choi Y, Park B, Jeong BC, et al: Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis. Int J Cancer 132:625-634, 2013
14. Reeves GK, Pirie K, Beral V, et al: Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 335:1134, 2007
15. Lee WK, Hong SK, Lee S, et al: Prognostic value of body mass index according to histologic subtype in nonmetastatic renal cell carcinoma: A large cohort analysis. Clin Genitourin Cancer 13:461-468, 2015
16. Renehan AG, Tyson M, Egger M, et al: Bodymass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578, 2008
17. De Nunzio C, Albisinni S, Freedland SJ, et al: Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study. Urol Oncol 31:997-1002, 2013
18. Tewari R, Rajender S, Natu SM, et al: Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study. Cytokine 63:130-134, 2013
19. Larsson SC, Wolk A: Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies. Int J Cancer 122:1418-1421, 2008
20. Adams KF, Leitzmann MF, Albanes D, et al: Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168:268-277, 2008
21. Pischon T, Lahmann PH, Boeing H, et al: Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:728-738, 2006
22. Whitlock G, Lewington S, Sherliker P, et al: Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 373:1083-1096, 2009
23. Fowke JH, McLerran DF, Gupta PC, et al: Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol 182:381-389, 2015
24. Burton AJ, Tilling KM, Holly JM, et al: Metabolic imbalance and prostate cancer progression. Int J Mol Epidemiol Genet 1:248-271, 2010
25. Presti JC, Jr: Obesity and prostate cancer. Curr Opin Urol 15:13-16, 2005
26. Li H, Stampfer MJ, Mucci L, et al: A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem 56:34-43, 2010
27. Ma J, Li H, Giovannucci E, et al: Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: A long-term survival analysis. Lancet Oncol 9:1039-1047, 2008
28. MacInnis RJ, English DR: Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis. Cancer Causes Control 17:989-1003, 2006
29. Bañez LL, Hamilton RJ, Partin AW, et al: Obesityrelated plasma hemodilution and PSA concentration amongmen with prostate cancer. JAMA 298:2275-2280, 2007
30. Loeb S, Yu X, Nadler RB, et al: Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 177:102-106, discussion 106, 2007
31. Su LJ, Arab L, Steck SE, et al: Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Cancer Epidemiol Biomarkers Prev 20:844-853, 2011
32. Allott EH, Masko EM, Freedland SJ: Obesity and prostate cancer: Weighing the evidence. Eur Urol 63:800-809, 2013
33. Strom SS, Kamat AM, Gruschkus SK, et al: Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107:631-639, 2006
34. Davies BJ, Smaldone MC, Sadetsky N, et al: The impact of obesity on overall and cancer specific survival in men with prostate cancer. J Urol 182:112-117, 2009; discussion 117
35. Bassett WW, Cooperberg MR, Sadetsky N, et al: Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE. Urology 66:1060-1065, 2005
36. Freedland SJ, Aronson WJ, Kane CJ, et al: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22:446-453, 2004
37. Giovannucci E, Liu Y, Platz EA, et al: Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121:1571-1578, 2007
38. Rodriguez C, Freedland SJ, Deka A, et al: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16:63-69, 2007
39. Wright ME, Chang SC, Schatzkin A, et al: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109:675-684, 2007
40. Chalfin HJ, Lee SB, Jeong BC, et al: Obesity and long-term survival after radical prostatectomy. J Urol 192:1100-1104, 2014
41. Asmar R, Beebe-Dimmer JL, Korgavkar K, et al: Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 16:62-66, 2013
42. Ly D, Reddy CA, Klein EA, et al: Association of body mass index with prostate cancer biochemical failure. J Urol 183:2193-2199, 2010
43. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA, American Cancer Society, 2008
44. American Cancer Society. Cancer Facts & Figures for African Americans 2011-2012. Atlanta, GA, American Cancer Society, 2011
45. Motamedinia P, Korets R, Spencer BA, et al: Body mass index trends and role of obesity in predicting outcome after radical prostatectomy. Urology 72:1106-1110, 2008
46. Keto CJ, Aronson WJ, Terris MK, et al: Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: Results from the SEARCH database. BJU Int 110:492-498, 2012
47. Joshu CE, Mondul AM, Menke A, et al: Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 4:544-551, 2011
48. Flegal KM, Carroll MD, Ogden CL, et al: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241, 2010
49. Caire AA, Sun L, Polascik TJ, et al: Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of, 10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans. BJU Int 106:1157-1160, 2010
50. Johnsen NF, Tjønneland A, Thomsen BL, et al: Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 125:902-908, 2009
51. Giovannucci E, Leitzmann M, Spiegelman D, et al: A prospective study of physical activity and prostate cancer in male health professionals. Cancer Res 58:5117-5122, 1998
52. Giovannucci EL, Liu Y, Leitzmann MF, et al: A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165:1005-1010, 2005
53. Nilsen TI, Romundstad PR, Vatten LJ: Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study). Int J Cancer 119:2943-2947, 2006
54. Patel AV, Rodriguez C, Jacobs EJ, et al: Recreational physical activity and risk of prostate cancer in a large cohort of U. S. men. Cancer Epidemiol Biomarkers Prev 14:275-279, 2005
55. Orsini N, Bellocco R, Bottai M, et al: A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 101:1932-1938, 2009
56. Wolin KY, Stoll C: Physical activity and urologic cancers. Urol Oncol 30:729-734, 2012
57. Liu Y, Hu F, Li D, et al: Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 60:1029-1044, 2011
58. Carson KR, Bartlett NL, McDonald JR, et al: Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol 30:3217-3222, 2012
59. Weiss L, Melchardt T, Habringer S, et al: Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Ann Oncol 25:171-176, 2014
60. Hwang HS, Yoon DH, Suh C, et al: Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified. Ann Hematol 94:1655-1665, 2015
61. Leo QJ, Ollberding NJ, Wilkens LR, et al: Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: The Multiethnic Cohort study. Cancer Causes Control 25:1449-1459, 2014
62. Chu DM, Wahlqvist ML, Lee MS, et al: Central obesity predicts non-Hodgkin's lymphoma mortality and overall obesity predicts leukemia mortality in adult Taiwanese. J Am Coll Nutr 30:310-319, 2011
63. Park S, Han B, Cho JW, et al: Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Nutr Cancer 66:225-233, 2014
64. Navarro WH, Loberiza FR, Jr., Bajorunaite R, et al: Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:541-551, 2006
65. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA Cancer J Clin 66:7-30, 2016
66. Rodriguez-Abreu D, Bordoni A, Zucca E: Epidemiology of hematological malignancies. Ann Oncol 18:i3-i8, 2007
67. Wenzell CM, Gallagher EM, Earl M, et al: Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight. Am J Hematol 88:906-909, 2013
68. Tavitian S, Denis A, Vergez F, et al: Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy. Am J Hematol 91:193-198, 2016
69. Medeiros BC, Othus M, Estey EH, et al: Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica 97:1401-1404, 2012
70. World Cancer Research Fund. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC, AICR, 2007
71. Beral V, Bull D, Green J, et al: Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369:1703-1710, 2007
72. Hakimi AA, Furberg H, Zabor EC, et al: An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105:1862-1870, 2013
73. Hourdequin KC, Schpero WL, McKenna DR, et al: Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: A systematic review and meta-analysis. Ann Oncol 24:2952-2962, 2013
74. Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 140:883-899, 2010
75. Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886-895, 2011
76. Nguyen PL, Ma J, Chavarro JE, et al: Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol 28:3958-3964, 2010
77. Ligibel JA, Alfano CM, Courneya KS, et al: American Society of Clinical Oncology position statement on obesity and cancer. JClin Oncol 32:3568-3574, 2014
78. Rock CL, Doyle C, Demark-Wahnefried W, et al: Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243-274, 2012
79. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010